Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab

Inflammatory Bowel Diseases

Volumn 17, Issue 4, 2011, Pages 1060-1061

  Nancey, S ^a   Boschetti, G ^a   Cotte, E ^a   Cathey Javouhay, A ^b   Laidet, M ^a   Chichery, A ^b   Francois, Y ^a   Glehen, O ^a   Flourie B ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b Centre Hospitalier Saint Luc Saint Joseph   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; STEROID;

ADULT; CASE REPORT; COLON ANASTOMOSIS; COLON RESECTION; COLONOSCOPY; CROHN DISEASE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; ILEUM RESECTION; INTESTINE OBSTRUCTION; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN DEFECT; SKIN GRAFT; SKIN INFLAMMATION; SKIN SURGERY; SQUAMOUS CELL CARCINOMA;

EID: 79952457521     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21433     Document Type: Letter

References (8)

1. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010 [Epub ahead of print].
2. De Hertog SAE, Wensveen AH, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol. 2001;19:231-238. (Pubitemid 32063501)
3. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc. 1991;23:1101-1103.
4. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc. 1995;27:1767-1768.
5. Kerbleski JF, Gottlieb AB. Dermatological complications and safety of anti-TNF treatments. Gut. 2009;58:1033-1039.
6. Esser AC, Abril A, Fayne S, et al. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol. 2004;50:S75-77.
7. Smith KJ, Skelton HG. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor a receptor IgG1-Fc fusion complex therapy. J Am Acad Dermatol. 2001;45:953-956. (Pubitemid 33096643)
8. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871-1874. (Pubitemid 41325100)